Techno Medica Co., Ltd.
6678.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.75 | 0.38 | -1.45 | 0.93 |
| FCF Yield | 7.84% | 7.62% | 4.68% | 14.95% |
| EV / EBITDA | 2.18 | 2.60 | 2.41 | 0.89 |
| Quality | ||||
| ROIC | 6.75% | 9.47% | 6.85% | 8.12% |
| Gross Margin | 49.15% | 50.10% | 49.43% | 49.67% |
| Cash Conversion Ratio | 0.97 | 0.85 | 0.53 | 1.11 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.88% | 1.97% | 1.19% | -0.38% |
| Free Cash Flow Growth | -8.44% | 39.01% | -62.25% | 150.51% |
| Safety | ||||
| Net Debt / EBITDA | -6.38 | -4.40 | -6.69 | -5.90 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.93 | 2.38 | 2.54 | 3.97 |
| Cash Conversion Cycle | 220.44 | 178.24 | 167.45 | 133.45 |